Neodol 100 Mg Oralna Suspenzija (Ibuprofen)

Ibuprofen, the active ingredient in Neodol 100 Mg Oralna Suspenzija, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a 100 mg oral suspension for oral use. It treats pain, fever and inflammation in children and adults.

GNH USA supplies Neodol 100 Mg Oralna Suspenzija as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen, an NSAID, provides symptomatic relief by reducing inflammation and fever in several common conditions.

Pain: alleviates mild to moderate pain such as headache, toothache, musculoskeletal discomfort. Fever: reduces elevated body temperature associated with infections or other causes. Inflammation: decreases swelling and discomfort in conditions like sprains, strains, and minor arthritis.

Ibuprofen may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastro‑intestinal discomfort such as nausea, dyspepsia or mild abdominal pain. - Headache. - Dizziness or light‑headedness. - Transient rash or mild skin irritation. - Mild elevation of liver enzymes. - Increased urinary frequency.

Serious or Rare Side Effects: - Gastro‑intestinal ulceration or bleeding, which can be life‑threatening. - Severe allergic reactions including anaphylaxis, angioedema or Stevens‑Johnson syndrome. - Hepatotoxicity manifesting as hepatitis or marked liver enzyme rise. - Acute kidney injury or renal failure, especially in volume‑depleted patients. - Cardiovascular events such as myocardial infarction or stroke in high‑risk individuals. - Hematologic abnormalities like thrombocytopenia.

Before using Neodol 100 Mg Oralna Suspenzija, consider the following safety measures.

Assess renal function: avoid use in patients with severe kidney disease. Evaluate gastrointestinal risk: use with food in those with a history of ulcer or bleeding. Avoid concurrent anticoagulants: increased bleeding risk when combined with warfarin or DOACs. Do not use in children under 3 months or weighing less than 5 kg unless specifically advised by a clinician. Monitor for asthma exacerbation: ibuprofen may trigger bronchospasm in susceptible individuals. Store at ambient temperature: keep in the original container, protect from moisture and light.

Ibuprofen can interact with several medicines; awareness of major and moderate interactions helps minimise risk.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin, direct oral anticoagulants): heightened bleeding risk. - Other NSAIDs or systemic corticosteroids: additive gastrointestinal toxicity. - ACE inhibitors or diuretics: may impair renal function, especially in dehydrated patients.

Moderate Interactions (Monitor Closely): - Lithium: ibuprofen can increase serum lithium concentrations. - Methotrexate: concurrent use may raise methotrexate levels and toxicity. - SSRIs or SNRIs: modest increase in bleeding tendency when combined.